Rubella screening: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(9 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Rubella}}
{{Rubella}}
{{CMG}}
{{CMG}}; {{AE}} {{MJM}}, {{AKI}}
{{MJM}}


Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
==Overview==
There are no standard screening test recommended for [[rubella]] [[infection]], however [[Pregnancy|pregnant]] women with suspected [[rubella]] [[infection]] must be investigated to confirm the diagnosis to prevent fetal anomalies.<ref name="pmid21267342">{{cite journal| author=Gerace TM| title=Rubella screening and immunization: its history and future-an ongoing challenge. | journal=Can Fam Physician | year= 1987 | volume= 33 | issue= | pages= 111-5 | pmid=21267342 | doi= | pmc=2218305 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21267342  }} </ref>


==Overview==
==Screening==
There is no screening test for rubella.
There is no screening test for [[rubella]], however, if there is a high clinical suspicion of [[rubella]] infection during [[pregnancy]], [[serum]] [[IgG]] and [[IgM]] [[antibodies]] against [[rubella]] may be ordered. Also, if a [[pregnant]] woman proves to be not [[immune]] aganist [[rubella]], [[vaccination]] with [[MMR]] should be deferred till after delivery due to the theoretical [[teratogenic]] effects of the [[rubella]] [[vaccine]].<ref name="USPSTF">U.S. Preventive Services Task Force https://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=congenital+rubella+syndrome. Accessed on Jan 17, 2017.</ref><ref name="CDC"> Center for Disease Control and Prevention https://www.cdc.gov/vaccines/pubs/surv-manual/chpt14-rubella.html. Accessed on Jan 17, 2017.</ref><ref name="pmid28370103">{{cite journal| author=Snell LB, Smith C, Chaytor S, McRae K, Patel M, Griffiths P| title=Screening for potential susceptibility to rubella in an antenatal population: A multivariate analysis. | journal=J Med Virol | year= 2017 | volume=  | issue=  | pages=  | pmid=28370103 | doi=10.1002/jmv.24818 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28370103  }} </ref>


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WH}}
{{WS}}


[[Category:Teratogens]]
[[Category:Teratogens]]
Line 16: Line 19:
[[Category:Pediatrics]]
[[Category:Pediatrics]]
[[Category:Togaviruses]]
[[Category:Togaviruses]]
[[Category:Infectious disease]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:Primary care]]
[[Category:Needs content]]
[[Category:Needs content]]
 
[[Category:Emergency mdicine]]
{{WH}}
[[Category:Disease]]
{{WS}}
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Dermatology]]

Latest revision as of 00:04, 30 July 2020

Rubella Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Rubella from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Case Studies

Case #1

Rubella screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rubella screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rubella screening

CDC on Rubella screening

Rubella screening in the news

Blogs on Rubella screening

Directions to Hospitals Treating Rubella

Risk calculators and risk factors for Rubella screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Michael Maddaleni, B.S., Aravind Kuchkuntla, M.B.B.S[2]

Overview

There are no standard screening test recommended for rubella infection, however pregnant women with suspected rubella infection must be investigated to confirm the diagnosis to prevent fetal anomalies.[1]

Screening

There is no screening test for rubella, however, if there is a high clinical suspicion of rubella infection during pregnancy, serum IgG and IgM antibodies against rubella may be ordered. Also, if a pregnant woman proves to be not immune aganist rubella, vaccination with MMR should be deferred till after delivery due to the theoretical teratogenic effects of the rubella vaccine.[2][3][4]

References

  1. Gerace TM (1987). "Rubella screening and immunization: its history and future-an ongoing challenge". Can Fam Physician. 33: 111–5. PMC 2218305. PMID 21267342.
  2. U.S. Preventive Services Task Force https://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=congenital+rubella+syndrome. Accessed on Jan 17, 2017.
  3. Center for Disease Control and Prevention https://www.cdc.gov/vaccines/pubs/surv-manual/chpt14-rubella.html. Accessed on Jan 17, 2017.
  4. Snell LB, Smith C, Chaytor S, McRae K, Patel M, Griffiths P (2017). "Screening for potential susceptibility to rubella in an antenatal population: A multivariate analysis". J Med Virol. doi:10.1002/jmv.24818. PMID 28370103.

Template:WH Template:WS